Frances D. Schulz's most recent trade in Senti Biosciences Inc. was a trade of 21,950 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Senti Biosciences Inc | Frances D. Schulz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 21,950 | 21,950 | - | - | Stock Option (Right to Buy) | |
| Senti Biosciences Inc | Frances D. Schulz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 43,900 | 43,900 | - | - | Stock Option (Right to Buy) | |
| Senti Biosciences Inc | Frances Schulz D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) |